健脾利湿通络方治疗2型糖尿病合并高尿酸血症临床观察
Clinical observation of Jianpi Lishi Tongluo Decoction in treating type 2 diabetes mellitus with hyperuricemia
- 北京中医药 2022年41卷第10期 页码：1110-1114
- 作者机构：
1.首都医科大学中医药学院，北京 100069
2.首都医科大学附属北京中医医院肾病科，北京 100010
- 作者简介：
邢俊艳，女，25岁，硕士研究生。研究方向：中医药防治糖尿病及其并发症。
高彦彬，E-mail：15911150133@163.com
- 基金信息：国家重点研发计划项目(2018YFC1704100;2018YFC1704102)
DOI：10.16025/j.1674-1307.2022.10.007
中图分类号：
扫 描 看 全 文
邢俊艳，孟元，李益萌，等.健脾利湿通络方治疗2型糖尿病合并高尿酸血症临床观察［J］.北京中医药，2022，41（10）：1110-1114.
XING Jun-yan,MENG Yuan,LI Yi-meng,et al.Clinical observation of Jianpi Lishi Tongluo Decoction in treating type 2 diabetes mellitus with hyperuricemia[J]. Beijing Journal of Traditional Chinese Medicine,2022,41(10):1110-1114.
邢俊艳，孟元，李益萌，等.健脾利湿通络方治疗2型糖尿病合并高尿酸血症临床观察［J］.北京中医药，2022，41（10）：1110-1114. DOI： 10.16025/j.1674-1307.2022.10.007.
XING Jun-yan,MENG Yuan,LI Yi-meng,et al.Clinical observation of Jianpi Lishi Tongluo Decoction in treating type 2 diabetes mellitus with hyperuricemia[J]. Beijing Journal of Traditional Chinese Medicine,2022,41(10):1110-1114. DOI： 10.16025/j.1674-1307.2022.10.007.
摘要
目的,2,观察健脾利湿通络方治疗2型糖尿病合并高尿酸血症的临床疗效。,方法,2,选择2020年1月—2021年7月于首都医科大学附属北京中医医院肾病科、内分泌科就诊的2型糖尿病合并高尿酸血症患者72例，根据随机数字表法分为治疗组、对照组各36例。2组均采用糖尿病规范化治疗，治疗组加服健脾利湿通络方，1剂/d，早晚分服；对照组加服苯溴马隆，50 mg/d，1次/d。2组疗程均为8周。对比2组中医证候疗效、尿酸（UA）疗效，比较2组治疗前后中医证候积分及空腹血糖（FBG）、餐后2小时血糖（2 h PBG）、糖化血红蛋白（HbA1C）、UA、一氧化氮（NO）、黄嘌呤氧化酶（XOD）、超敏C反应蛋白（hs-CRP）、白细胞介素6（IL-6）水平。,结果,2,治疗组中医证候总有效率高于对照组，差异有统计学意义（,P,<,0.05），UA总有效率2组差异无统计学意义（,P,>,0.05）。治疗组治疗后中医证候积分、FBG、2 h PBG、HbA1C、UA、XOD、hs-CRP、IL-6水平低于对照组（,P,<,0.05），NO水平高于对照组（,P,<,0.05）。,结论,2,与苯溴马隆相比，健脾利湿通络方治疗2型糖尿病合并高尿酸血症安全有效，其疗效机制可能与调控氧化应激和炎症反应有关。
Abstract
Objective,2,To observe the clinical efficacy of Jianpi Lishi Tongluo Decoction in the treatment of type 2 diabetes patients with hyperuricemia.,Methods,2,According to the random number table method，72 patients with type 2 diabetes patients complicated with hyperuricemia， who visited Outpatients and wards of Department of Nephrology and Endocrinology， Beijing Hospital of Traditional Chinese Medicine， affiliated to the Capital Medical University， were selected and divided into treatment group and control group，36 patients in each group. The two groups of patients were treated with standardized diabetes treatment， the treatment group plus Jianpi Lishi Tongluo Decoction，one pachage per day，once in the morning and once in the evening；the control group was given benzbromarone，50 mg/day，once a day. The curative effects of TCM syndromes and uric acid （UA） were compared between the two groups. Fasting blood glucose （FBG）， 2 h PBG， HbA1C， UA， NO， Xanthine oxidase （XOD）， hs-CRP， IL-6 and TCM symptom score in treatment group and control group before and after treatment were observed and compared.,Results,2,The total effective rate of TCM syndromes in the treatment group was higher than that in the control group， there was no statistically significant difference in UA total effective rate（,P,>,0.05）. After treatment，the indexes of FBG， 2 h PBG， HbA1C，UA， XOD， hs-CRP and IL-6 and the TCM syndrome scores in the treatment group were significantly lower than those in the control group （,P,<,0.05），and the content of NO was significantly higher than that in the control group （,P,<,0.05）.,Conclusion,2,Compared with benbromarone group，Jianpi Lishi Tongluo Decoction is safe and effective in the treatment of type 2 diabetes patients with hyperuricemia，and its therapeutic mechanism may be related to oxidative stress and inflammatory response.
关键词
2型糖尿病高尿酸血症健脾利湿通络方氧化应激炎症反应
Keywords
Type 2 diabeteshyperuricemiaJianpi Lishi Tongluo Decoctionoxidative stressinflammatory reaction
references
钱远宇, 孟庆义, 杨晓秋,等. 老年2型糖尿病合并高尿酸与心室重构的关系[J]. 天津医药,2007,35(4):288-289.
MORTADA I.Hyperuricemia,type 2 diabetes mellitus, and hypertension:an emerging association[J].Curr hypertens Rep,2017,19(9):1-5.
周凯伦. 参苓二术汤治疗2型糖尿病合并高尿酸血症的临床观察[D]. 南京:南京中医药大学,2018.
REN Y,GAO L,GUO X,et al.Interactive effect of serum uric acid and total bilirubin for micro-vascular disease of type 2 diabetes in China[J].J Diabetes Compl,2018,32(11):1000-1005.
曹雪霞，王立,血尿酸对2型糖尿病血管并发症的影响及相关因子分析[J].中国糖尿病杂志,2006,14(3):182-184.
LI Q,LI X,WANG J,et al.Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements[J].BMJ Open,2019,9(8):026677.
陈蕾，伍成凯,康峻鸣,等,我国45岁及以上中老年人群高尿酸血症与常见慢性病的关联研究[J].中国全科医学,2021,24(4):447-452.
中国2型糖尿病防治指南(2017年版)[J].中华糖尿病杂志,2018,10(1):4-67.
中国高尿酸血症与痛风诊疗指南(2019)[J].中华内分泌代谢杂志,2020,36(1):1-13.
郑筱萸，中药新药临床研究指导原则[M].北京:中国医药科技出版,2002:233-237.
田德禄.中医内科学[M].北京:人民卫生出版,2002:322-329.
高尿酸血症和痛风治疗的中国专家共识[J].中华内分泌代谢杂志,2013,29(11):913-920.
中华中医药学会.第十二届全国中医糖尿病大会论文汇编[C].北京:中华中医药学会糖尿病分会,2010:65-68.
韩笑,朴春丽,南征.南征教授诊治消渴痛风经验探讨[J].国医论坛,2015,30(2):31-32.
娄妍.白虎二地汤加减治疗2型糖尿病合并高尿酸血症的临床疗效观察[D].南京:南京中医药大学,2017.
苏祖清,曾科学,孙朝跃,等,白术挥发油对代谢综合征大鼠糖脂代谢的影响[J].亚太传统医药,2018,14(10):4-7
汪锦飘，刘永茂,何志超,等,泽泻乙醇提取物对氧嗪酸钾盐致大鼠高尿酸血症模型的影响[J].中成药,2017,39(3):605-608.
孙红,王少明,庄捷,等,土茯苓等中药抑制URAT1表达及降尿酸作用筛选研究[J].中国临床药理学与治疗学,2012,17(4):403-407.
WANG P,XU S,LI W,et al.Salvianolic acid B inhibited PPARγ expression and attenuated weight gain in mice with high-fat diet-induced obesity[J].Cell Physiol Biochem,2014,34(2):288-298.
JIA S,MA WD,ZHANG CY,et al.Tanshinone IIA attenuates high glucose induced human VSMC proliferation and migration through miR-21-5p-mediated tropomyosin 1 downregulation[J].Arch Biochem Biophys,2019,677:108154.
徐锦，梁志敏,刘智君,等,鸡矢藤提取物对2型糖尿病大鼠胰腺β细胞内质网应激的影响[J].中成药,2019,41(7):1694-1697.
毛长智,李冬梅,陆国寿,等,基于抗高尿酸血症活性的鸡矢藤物质基础研究[J].中国现代应用药学,2019,36(20):2502-2507.
魏书瑶,冯珊珊,马菲菲,等.氧化应激在2型糖尿病发生发展中的作用机制[J].西北国防医学杂志,2021,42(6):557-562.
0
浏览量
0
下载量
0
CSCD
- Meta-XML下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 技术支持由北京北大方正电子有限公司提供 京ICP备18046208号-2
京公网安备 11010102006710号 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies